Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Voss

Showing results (31-40 of 108) with videos related to

Pageof 11
Sort By:
Journal of Structural Biology|September 25, 2019
Arabidopsis immunity regulator EDS1 in a PAD4/SAG101-unbound form is a monomer with an inherently inactive conformationMartin Voss, Christine Toelzer, Deepak D Bhandari, et al.
Epilepsy & Behavior : E&B|May 18, 2020
Treatment of status epilepticus with zonisamide: A multicenter cohort study of 34 patients and review of literatureKristina Hubert, Susanne Knake, Sebastian Bauer, et al.
Plos One|December 24, 2011
Whodunnit? Electrophysiological correlates of agency judgementsSimone Kühn, Ivan Nenchev, Patrick Haggard, et al.
Brain : a Journal of Neurology|August 6, 2010
Altered awareness of action in schizophrenia: a specific deficit in predicting action consequencesMartin Voss, James Moore, Marta Hauser, et al.
Plos One|March 10, 2017
PA28 modulates antigen processing and viral replication during coxsackievirus B3 infectionDorota Respondek, Martin Voss, Ina Kühlewindt, et al.
Frontiers in Behavioral Neuroscience|June 18, 2015
Fronto-limbic novelty processing in acute psychosis: disrupted relationship with memory performance and potential implications for delusionsBjörn H Schott, Martin Voss, Benjamin Wagner, et al.
CNS Drugs|July 25, 2020
Therapeutic Options for Patients with Refractory Status Epilepticus in Palliative Settings or with a Limitation of Life-Sustaining Therapies: A Systematic ReviewLaurent M Willems, Sebastian Bauer, Kolja Jahnke, et al.
CNS Drugs|July 27, 2021
Correction to: Therapeutic Options for Patients with Refractory Status Epilepticus in Palliative Settings or with a Limitation of Life‑Sustaining Therapies: A Systematic ReviewLaurent M Willems, Sebastian Bauer, Kolja Jahnke, et al.
The European Journal of Neuroscience|November 3, 2005
High-frequency repetitive transcranial magnetic stimulation over the hand area of the primary motor cortex disturbs predictive grip force scalingDennis A Nowak, Martin Voss, Ying-Zu Huang, et al.
Frontiers in Immunology|January 25, 2021
Screening of FDA-Approved Drug Library Identifies Adefovir Dipivoxil as Highly Potent Inhibitor of T Cell ProliferationLinda Voss, Karina Guttek, Annika Reddig, et al.
Pageof 11

Showing results (31-40 of 108) with videos related to

Sort By:
Pageof 11
Journal of Structural Biology|September 25, 2019
Arabidopsis immunity regulator EDS1 in a PAD4/SAG101-unbound form is a monomer with an inherently inactive conformationMartin Voss, Christine Toelzer, Deepak D Bhandari, et al.
Epilepsy & Behavior : E&B|May 18, 2020
Treatment of status epilepticus with zonisamide: A multicenter cohort study of 34 patients and review of literatureKristina Hubert, Susanne Knake, Sebastian Bauer, et al.
Plos One|December 24, 2011
Whodunnit? Electrophysiological correlates of agency judgementsSimone Kühn, Ivan Nenchev, Patrick Haggard, et al.
Brain : a Journal of Neurology|August 6, 2010
Altered awareness of action in schizophrenia: a specific deficit in predicting action consequencesMartin Voss, James Moore, Marta Hauser, et al.
Plos One|March 10, 2017
PA28 modulates antigen processing and viral replication during coxsackievirus B3 infectionDorota Respondek, Martin Voss, Ina Kühlewindt, et al.
Frontiers in Behavioral Neuroscience|June 18, 2015
Fronto-limbic novelty processing in acute psychosis: disrupted relationship with memory performance and potential implications for delusionsBjörn H Schott, Martin Voss, Benjamin Wagner, et al.
CNS Drugs|July 25, 2020
Therapeutic Options for Patients with Refractory Status Epilepticus in Palliative Settings or with a Limitation of Life-Sustaining Therapies: A Systematic ReviewLaurent M Willems, Sebastian Bauer, Kolja Jahnke, et al.
CNS Drugs|July 27, 2021
Correction to: Therapeutic Options for Patients with Refractory Status Epilepticus in Palliative Settings or with a Limitation of Life‑Sustaining Therapies: A Systematic ReviewLaurent M Willems, Sebastian Bauer, Kolja Jahnke, et al.
The European Journal of Neuroscience|November 3, 2005
High-frequency repetitive transcranial magnetic stimulation over the hand area of the primary motor cortex disturbs predictive grip force scalingDennis A Nowak, Martin Voss, Ying-Zu Huang, et al.
Frontiers in Immunology|January 25, 2021
Screening of FDA-Approved Drug Library Identifies Adefovir Dipivoxil as Highly Potent Inhibitor of T Cell ProliferationLinda Voss, Karina Guttek, Annika Reddig, et al.
Pageof 11